β-Resorcylic acid prevents MASLD in ob/ob mice by modulating lipid metabolism and inflammation in the liver
Pharmacological Research · 2025
DOI: 10.1016/j.phrs.2025.107906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2025. Verfasst von Sergio López-Herrador und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biosanitaria Ibs.Granada, Granada 18016, Spain; Departamento de Fisiología, Facultad de Medicina, Universidad de Granada, …. Hauptthemen laut MEDLINE: Lipid Metabolism, Liver, Fatty Liver, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Regional Government of Andalusia Ministry of Health and Consumer Affairs, Andalucia Innovation and Development Agency.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a significant global health challenge. MALSD is primarily driven by metabolic dysfunction, including mitochondrial dysregulation. Here, we show that β-resorcylic acid (β-RA), a naturally derived phenolic molecule known to target mitochondrial Coenzyme Q biosynthesis, reduces hepatic steatosis and inflammation, thus preventing the progression to MASH in the leptin-deficient ob/ob mouse model. Early transcriptomic analyses revealed that β-RA activates HNF4α, a key regulator of lipid metabolism, leading to reductions in both macrosteatosis and microsteatosis. Furthermore, β-RA suppressed neutrophil degranulation and downregulated inflammatory markers, including Mpo, Anxa5, and Ly6d. These effects correlated with reductions in markers of hepatic injury, such as serum ALT and AST levels and hepatocyte ballooning. In line with these in vivo findings, β-RA also reduced neutral lipid accumulation in human HepG2 hepatocytes exposed to oleic and palmitic acids, confirming its anti-steatotic effect in a translational cellular model of fatty acid-induced steatosis. Overall, these findings identify β-RA as a promising therapeutic candidate for MASLD, with the ability to prevent MASH progression independently of leptin. Further research is needed to explore its translational potential in human MASLD and its integration with other therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigación Biosanitaria Ibs.Granada, Granada 18016, Spain; Departamento de Fisiología, Facultad de Medicina, Universidad de Granada, Granada 18016, Spain; Instituto de Biotecnología, Centro de Investigac…
- Departamento de Fisiología, Facultad de Medicina, Universidad de Granada, Granada 18016, Spain.
- Departamento de Genética, Facultad de Ciencias, Universidad de Granada, Fuentenueva S/N, Granada 18002, Spain.
Förderung
- European Regional Development Fund
- Regional Government of Andalusia Ministry of Health and Consumer Affairs
- Andalucia Innovation and Development Agency
- State Agency of Research
- Ministerio de Universidades
- Universidad de Granada
- Consejería de Salud y Familias, Junta de Andalucía
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
López-Herrador, S., Torres-Rusillo, S., González-García, P., Jiménez-Sánchez, L., Corral-Sarasa, J., Bakkali, M., Díaz-Casado, M. E., & López, L. C. (2025). β-Resorcylic acid prevents MASLD in ob/ob mice by modulating lipid metabolism and inflammation in the liver. Pharmacological Research. https://doi.org/10.1016/j.phrs.2025.107906
Vancouver
López-Herrador S, Torres-Rusillo S, González-García P, Jiménez-Sánchez L, Corral-Sarasa J, Bakkali M, et al. β-Resorcylic acid prevents MASLD in ob/ob mice by modulating lipid metabolism and inflammation in the liver. Pharmacological Research. 2025. doi:10.1016/j.phrs.2025.107906
BibTeX
@article{LpezHerrador2025,
author = {López-Herrador, Sergio and Torres-Rusillo, Sara and González-García, Pilar and Jiménez-Sánchez, Laura and Corral-Sarasa, Julia and Bakkali, Mohammed and Díaz-Casado, M Elena and López, Luis C},
title = {β-Resorcylic acid prevents MASLD in ob/ob mice by modulating lipid metabolism and inflammation in the liver},
journal = {Pharmacological Research},
year = {2025},
doi = {10.1016/j.phrs.2025.107906}
}
EUVIMED